Active Ingredient History
Diphenylcyclopropenone (diphencyprone) is a topically administered experimental drug intended for treating alopecia areata and alopecia totalis. Topical immunotherapy using diphenylcyclopropenone may also be an effective treatment option for recalcitrant warts. It is not approved by either the Food and Drug Administration or the European Medicines Agency. Wikipedia
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Alopecia Areata (Phase 3)
Human papillomavirus 16 (Phase 2)
Hypersensitivity, Delayed (Phase 1)
Immunosuppression Therapy (Phase 1)
Melanoma (Phase 1)
Neoplasm Metastasis (Phase 1)
Pharmacokinetics (Phase 1)
Ultraviolet Rays (Phase 1)
Vitiligo (Phase 4)
Warts (Phase 2)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue